Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

HKSE 2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 5.76%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Return on Capital Employed (ROCE) is 5.76% for the year ending December 31, 2023, a -23.21% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 7.50%, a -30.12% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 10.73%, a 20.73% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 8.89%, a -6.88% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 9.54%, a 125.30% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
HKSE: 2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

CEO Mr. Deyong Wen
IPO Date Oct. 30, 2012
Location China
Headquarters Building A
Employees 40,370
Sector Health Care
Industries
Pharmaceuticals Drugstores & Retail Pharmacies
Description

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Similar companies

2607.HK

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.58

1.46%

1099.HK

Sinopharm Group Co. Ltd.

USD 2.59

1.33%

1177.HK

Sino Biopharmaceutical Limited

USD 0.37

1.03%

2269.HK

WuXi Biologics (Cayman) Inc.

USD 2.26

4.12%

StockViz Staff

January 15, 2025

Any question? Send us an email